These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 20387211)
1. [Cell encapsulation for the treatment of central nervous system disorders]. Portero A; Orive G; Hernández RM; Pedraz JL Rev Neurol; 2010 Apr; 50(7):409-19. PubMed ID: 20387211 [TBL] [Abstract][Full Text] [Related]
2. Update on immunoisolation cell therapy for CNS diseases. Emerich DF; Salzberg HC Cell Transplant; 2001; 10(1):3-24. PubMed ID: 11294469 [TBL] [Abstract][Full Text] [Related]
3. Immunoisolation cell therapy for CNS diseases. Emerich DF; Winn SR Crit Rev Ther Drug Carrier Syst; 2001; 18(3):265-98. PubMed ID: 11442201 [TBL] [Abstract][Full Text] [Related]
4. [Cell and ex vivo gene therapy: advances in the treatment of central nervous system disorders]. Mejía-Toiber J; Castillo CG; Giordano M Rev Neurol; 2009 Nov 1-15; 49(9):483-9. PubMed ID: 19859890 [TBL] [Abstract][Full Text] [Related]
5. Overview: H3 histamine receptor isoforms: new therapeutic targets in the CNS? Chazot PL; Hann V Curr Opin Investig Drugs; 2001 Oct; 2(10):1428-31. PubMed ID: 11890359 [No Abstract] [Full Text] [Related]
6. Neural precursor cells: applications for the study and repair of the central nervous system. Fisher LJ Neurobiol Dis; 1997; 4(1):1-22. PubMed ID: 9258907 [TBL] [Abstract][Full Text] [Related]
7. Cell microencapsulation technology: towards clinical application. Murua A; Portero A; Orive G; Hernández RM; de Castro M; Pedraz JL J Control Release; 2008 Dec; 132(2):76-83. PubMed ID: 18789985 [TBL] [Abstract][Full Text] [Related]
8. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
9. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Begley DJ Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907 [TBL] [Abstract][Full Text] [Related]
10. The development of encapsulated cell technologies as therapies for neurological and sensory diseases. Zanin MP; Pettingill LN; Harvey AR; Emerich DF; Thanos CG; Shepherd RK J Control Release; 2012 May; 160(1):3-13. PubMed ID: 22285549 [TBL] [Abstract][Full Text] [Related]
11. Cell replacement therapies for central nervous system disorders. Björklund A; Lindvall O Nat Neurosci; 2000 Jun; 3(6):537-44. PubMed ID: 10816308 [TBL] [Abstract][Full Text] [Related]
12. Differential receptor-mediated drug targeting to the diseased brain. Rip J; Schenk GJ; de Boer AG Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042 [TBL] [Abstract][Full Text] [Related]
13. A cell encapsulation device for studying soluble factor release from cells transplanted in the rat brain. Kim YT; Hitchcock R; Broadhead KW; Messina DJ; Tresco PA J Control Release; 2005 Jan; 102(1):101-11. PubMed ID: 15653137 [TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of HEMA copolymers designed for treatment of CNS diseases with polymer-encapsulated cells. Mokrý J; Karbanová J; Lukás J; Palecková V; Dvoránková B Biotechnol Prog; 2000; 16(5):897-904. PubMed ID: 11027187 [TBL] [Abstract][Full Text] [Related]
16. Nanobiotechnology-based drug delivery to the central nervous system. Jain KK Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy and transplantation in CNS repair: the visual system. Harvey AR; Hu Y; Leaver SG; Mellough CB; Park K; Verhaagen J; Plant GW; Cui Q Prog Retin Eye Res; 2006 Sep; 25(5):449-89. PubMed ID: 16963308 [TBL] [Abstract][Full Text] [Related]
20. A role for fMRI in optimizing CNS drug development. Borsook D; Becerra L; Hargreaves R Nat Rev Drug Discov; 2006 May; 5(5):411-24. PubMed ID: 16604100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]